Clinical Trial Update: A Multicenter Trial of the Efficacy and Safety of a New Formulation of Ibuprofen 800 mg Every 6 Hours in the Management of Postoperative Pain [Phase 3]

View source ↗

Summary

Phase 3 multicenter trial evaluating a new ibuprofen 800 mg formulation for postoperative pain; the study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• Ibuprofen (IBUPROFEN)

Snippet

Sponsor: Biomendi S.A.U. | Conditions: Postoperative Pain | Phase 3 | Status: TERMINATED